FTSE flat early; oils offset gains in banks, pharmas
Britain's leading share index was flat early on Wednesday as gloom in commodity shares offset gains in banks and drugmakers.
bdnews24.com News Service
bdnews24.com
Published :
02 Apr 2008, 08:55 AM
Updated :
24 Apr 2022, 08:22 PM
LONDON, April 2 (bdnews24.com/Reuters) - Britain's leading share index was flat early on Wednesday as gloom in commodity shares offset gains in banks and drugmakers.
By 0807 GMT, the FTSE 100 was down 4.8 points at 5,847.8, after rallying 2.6 percent in the previous session.
Major European indexes were also up in early trading. Overnight, US stocks rallied after strong demand for a Lehman Brothers share offering quelled fears it was headed towards a fate similar to Bear Stearns and raised optimism that the worst of the credit crisis may be over.
Swiss bank UBS rose 1.5 percent a day after it unveiled fresh writedowns and a capital increase.
"We've got the writeoffs and the fund raising from UBS and Lehman. The market clearly wants to take that as a signal that the logjam is starting to ease," said Roger Cursley, UK strategist at Investec.
However, he said there were still a lot of problems to be worked out with the credit crisis.
"It's not going to be a straight ride from here," he said.
Banks were the standout gainers on the FTSE 100, with Barclays, Royal Bank of Scotland, HBOS, Lloyds TSB and Standard Chartered up between 0.7 and 3.2 percent.
HSBC, however, eased 0.8 percent after Hong Kong's South China Morning Post said the global banking group may make acquisitions in the United States and has no plans to pull out of that market despite the problems in the risky subprime mortgage sector.
Also in the financial sector, London Stock Exchange climbed 3 percent. The bourse said it would move trading of Italian equities to its trading system TradElect by the end of the year, aiming to generate cost synergies after the takeover of Borsa Italiana.
GlaxoSmithKline advanced 1.3 percent after researchers said the drugmaker's controversial diabetes drug Avandia, linked to increased heart attack risk, may prove to be effective in preventing the progression of blockages after heart surgery to repair narrowing arteries, according to a small study.
AstraZeneca put on 1.9 percent after Citi upgraded its rating on the drugmaker to "buy" from "hold".
U.S. Federal Reserve Chairman Ben Bernanke is due to testify on the economic outlook before Congress at 1330 GMT, while US factory orders data for February due at 1400 GMT will provide a further gauge of the strength of the world's largest economy.
Oil shares suffered, with BP off 0.6 percent, Royal Dutch Shell down 0.9 percent and Tullow Oil losing 3.3 percent.
Imperial Energy slumped 20 percent after the Russia-focused oil firm said it had signed an agreement with Hoare Govett and Merrill Lynch International for a standby equity underwriting commitment of up to $600 million.
In the mining sector, Xstrata was up 1.3 percent after a media report that Brazil's Vale held open the door for a possible restart in takeover talks with the Anglo-Swiss miner.
But the rest of the sector was generally weaker, with Anglo American down 1 percent, Antofagasta off 1.5 percent and Vedanta Resources dipping 0.4 percent.
bdnews24.com/lq/1452hrs